|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improved immume reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow显示文摘 | Ottinger HD Beelen DW Scheulen B | 1996 | Blood1996，88，7： | 1 |
| 2 | Phase Ⅱ study of nimotuzumab,a humanized monoclonal anti-epi- dermal growth factor receptor (EGFR) antibody in patients with locally advanced or metastatic pancreatic cancer显示文摘 | Strumberg D Schuhheis B Scheulen ME | 2012 | Invest New Drugs2012，30，3： | 1 |
| 3 | The detection of WF1 transcripts is not associated with an ingene WTI product 显示文摘 | Elmaagacli AH Bellen DW Scheulen B | 2005 | Expert Rev Vaccines2005，4，4： | 1 |
| 4 | Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study 显示文摘 | Strumberg D Scheulen M E Schultheis B | 2012 | Br J Cancer2012，106，11： | 1 |
| 5 | A phase I dose-escalation study of BI 811283,an Aurora B inhibitor, administered every three weeks in patients with advanced solid tumors 显示文摘 | MROSS K B SCHEULEN M E FROST A | 2010 | J Clin Oncol2010，28，15： | 1 |
| 6 | A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered day 1 and 15, every four weeks in patients with advanced solid tumors 显示文摘 | SCHEULEN M E MROSS K B RICHLY H | 2010 | J Clin Oncol2010，28，15： | 1 |
| 7 | Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow显示文摘 | Ottinger HD Beelen DW Scheulen B | | 0，，07： | 1 |
| 8 | The detection of WT1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic one marrow or peripheral blood stem cell transplantation显示文摘 | ELMAAGACLI A H BEELEN D W SCHEULEN B | 2000 | Bone Marrow Transplant2000，25，1： | 1 |
| 9 | Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow显示文摘 | Ottinger HD Beelen DW Scheulen B | 1996 | Blood1996，88，7： | 1 |
| 10 | Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow显示文摘 | Ottinger HD Beelen DW Scheulen B | 1996 | Blood1996，88，7： | 1 |
| 11 | Safety, efficacy and pharmacokinetics of nimotuzumab, a huma- nized monoclonal anti - epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer 显示文摘 | STRUMBERG D SCHULTHEIS B SCHEULEN M E | 2010 | Int J Clin Pharmacol Ther2010，48，7： | 1 |
| 12 | Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow显示文摘 | Ottingcr HD Beelen DW Scheulen B | 1996 | Blood1996，88，7： | 1 |
| 13 | Safety,efficacy and pharmacokinetics of nimotuzumab,a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody,in patients with locally advanced or metastatic pancreatic cancer显示文摘 | STRUMBERG D SCHULTHEIS B SCHEULEN M E | 2010 | Int J Clin Pharmacol Ther2010，48，7： | 1 |
| 14 | Regorafenib (BAY 734506) in advanced colorectal cancer: a phase I study显示文摘 | Stmmberg D Scheulen ME Schultheis B | 2012 | Br J Cancer2012，106，11： | 1 |
| 15 | 显示文摘 | Ottinger HD Beelen DW Scheulen B | 1996 | Blood1996，88，7： | 1 |
| 16 | The detection of WT1 transcripts is not associated with an ingene WT1 product 显示文摘 | Elmaagacli AH Bellen DW Scheulen B | 2005 | Expert Rev Vaccines2005，4，4： | 1 |
| 17 | Phase II study ofnimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor(EGFR) antibody,in patients with locally advanced or me- tastatic pancreatic cancer 显示文摘 | Strumberg D Schultheis B Scheulen ME | 2012 | Invest New Drugs2012，30，3： | 1 |
| 18 | Phase Ⅱ study of nimotuzumab,a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody,in patients with locally advanced or metastatic pancreatic cancer显示文摘 | Strumberg D Schultheis B Scheulen ME | 2012 | Invest New Drugs2012，30，： | 1 |
| 19 | Regorafenib ( BAY 73-4506) in advanced colorectal cancer: a phase I study 显示文摘 | Strumberg D Scheulen ME Schultheis B | 2012 | Br J Cancer2012，106，11： | 1 |
| 20 | Safety,efficacy and pharmacokinetics of nimotuzumab,a humanized monoclonal an-ti-epidermal growth factor receptor(EGFR)antibody,in patients with local y advanced or metastatic pancreatic cancer显示文摘 | Strumberg D Schultheis B Scheulen ME | | 0，，07： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员